11月3日 - Serina Therapeutics Inc :: *Serina Therapeutics提供关于SER-252项目的监管更新* Serina Therapeutics Inc - FDA对Serina的SER-252 IND申请施加了临床暂停* Serina Therapeutics Inc - FDA要求提供关于制剂中赋形剂的额外信息* Serina Therapeutics Inc - 预计将在30天内收到FDA正式的临床暂停函件
11月3日 - Serina Therapeutics Inc :: *Serina Therapeutics提供关于SER-252项目的监管更新* Serina Therapeutics Inc - FDA对Serina的SER-252 IND申请施加了临床暂停* Serina Therapeutics Inc - FDA要求提供关于制剂中赋形剂的额外信息* Serina Therapeutics Inc - 预计将在30天内收到FDA正式的临床暂停函件
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.